We are live on ! Find out more
DRUG

Bright Minds Biosciences
DRUG

31 hedge funds and large institutions have $176M invested in Bright Minds Biosciences in 2024 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

76,662% more capital invested

Capital invested by funds: $230K → $176M (+$176M)

2,500% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 1

417% more funds holding

Funds holding: 6 → 31 (+25)

76.25% more ownership

Funds ownership: 4.29% → 80.54% (+76%)

0% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 2

Holders
31
Holders Change
+25
Holders Change %
+416.67%
% of All Funds
0.41%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.01%
New
26
Increased
2
Reduced
2
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
CAM
Cormorant Asset Management
Massachusetts
+$37.3M
2
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$17.9M
3
CC
Commodore Capital
New York
+$17.6M
4
RCM
RA Capital Management
Massachusetts
+$16.2M
5
SCM
Sio Capital Management
New York
+$15.9M

Top Sellers

Rank Fund Capital Flow
1
AI
AdvisorShares Investments
Maryland
-$6.31M
2
National Bank of Canada
National Bank of Canada
Quebec, Canada
-$171K
3
APC
Aspire Private Capital
North Carolina
-$117
Name Holding Trade Value Shares
Change 		Change in
Stake
CAM
1
Cormorant Asset Management
Massachusetts
$38.2M +$37.3M +1,059,331 New
Janus Henderson Group
2
Janus Henderson Group
United Kingdom
$18.4M +$17.9M +508,776 New
CC
3
Commodore Capital
New York
$18M +$17.6M +500,000 New
RCM
4
RA Capital Management
Massachusetts
$16.6M +$16.2M +460,829 New
SCM
5
Sio Capital Management
New York
$16.3M +$15.9M +451,793 New
PA
6
Perceptive Advisors
New York
$14.5M +$14.2M +403,649 New
VC
7
Vivo Capital
California
$9.06M +$8.85M +251,572 New
LGM
8
Logos Global Management
California
$8.82M +$8.62M +245,000 New
Morgan Stanley
9
Morgan Stanley
New York
$6.04M +$5.9M +167,640 New
IC
10
Ikarian Capital
Texas
$5.48M +$5.36M +152,211 New
Point72 Asset Management
11
Point72 Asset Management
Connecticut
$4.87M +$4.76M +135,189 New
Adage Capital Partners
12
Adage Capital Partners
Massachusetts
$4.77M +$4.66M +132,500 New
Walleye Capital
13
Walleye Capital
New York
$3.72M +$3.63M +103,192 New
ACP
14
Acuta Capital Partners
California
$2.49M +$2.43M +69,124 New
SSA
15
Schonfeld Strategic Advisors
New York
$2.46M +$2.46M +69,812 New
SFAM
16
Springhill Fund Asset Management
Hong Kong
$2.18M +$2.13M +60,648 New
BFM
17
Boothbay Fund Management
New York
$1.61M +$1.57M +44,580 New
Millennium Management
18
Millennium Management
New York
$1.45M +$1.42M +40,379 New
ACM
19
Atika Capital Management
New York
$540K +$528K +15,000 New
UBS Group
20
UBS Group
Switzerland
$366K +$238K +6,754 +198%
Jane Street
21
Jane Street
New York
$238K +$232K +6,600 New
Bank of America
22
Bank of America
North Carolina
$173K +$169K +4,793 New
AI
23
AdvisorShares Investments
Maryland
$111K -$6.31M -179,345 -98%
Royal Bank of Canada
24
Royal Bank of Canada
Ontario, Canada
$29K +$5.56K +158 +24%
Osaic Holdings
25
Osaic Holdings
Arizona
$6.3K +$6.16K +175 New
1
2

DRUG Hedge Fund Activity: Q4 2024 in Review

31 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Bright Minds Biosciences (DRUG) for Q4 2024, worth a combined $176M — up 76,662% from $230K a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new DRUG positions and 1 closed out — a net gain of 25 holders — while 2 added to existing stakes and 2 trimmed.

The largest buyer was Cormorant Asset Management, opening a new position worth an estimated $37.3M. The largest seller was AdvisorShares Investments, cutting an estimated $6.31M.

  • 31 institutional investors held Bright Minds Biosciences (DRUG) as of Q4 2024, up from 6 in Q3 2024.
  • Funds reported $176M of Bright Minds Biosciences stock for Q4 2024, up 76,662% quarter-over-quarter.
  • 26 funds opened new Bright Minds Biosciences positions in Q4 2024 and 1 closed out, a net change of +25 holders.
  • The largest Bright Minds Biosciences buyer in Q4 2024 was Cormorant Asset Management, an estimated $37.3M added.
  • The largest Bright Minds Biosciences seller in Q4 2024 was AdvisorShares Investments, an estimated $6.31M sold.

Based on aggregated 13F filings for Q4 2024.